Molybdenum cofactor deficiency in a Malaysian child
1Clinical Genetic Unit, Paediatric Institute, Hospital Kuala Lumpur, Jalan Pahang, Kuala Lumpur 50586, Malaysia. ngulh@hotmail.com
Abstract:
Molybdenum cofactor deficiency is a rare autosomal recessive disorder with devastating neurological manifestations, characterised by neonatal-onset encephalopathy mimicking hypoxic-ischaemic insult, intractable seizure, and feeding and respiratory difficulties. It is often fatal in the early life. We report an affected 8-year-old boy, who presented with severe neurological manifestations since birth, but without clinically-significant seizure. Molybdenum cofactor deficiency must be included in the differential diagnosis of patients presenting with unexplained encephalopathy in the newborn period, and whose neuroimaging findings are consistent with hypoxic ischaemic encephalopathy. The classic laboratory hallmark of this disorder is low serum uric acid, positive urine sulphite dipstick test, and elevated urinary S-sulphocysteine, hypoxanthine and xanthine.
Insights
Molybdenum cofactor deficiency, a rare genetic disorder, causes severe neonatal encephalopathy. Early diagnosis is crucial, as this condition mimics hypoxic-ischaemic insult but has distinct laboratory markers.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Molybdenum cofactor deficiency is a rare, autosomal recessive genetic disorder.
- It presents with severe neurological symptoms, often fatal in infancy, mimicking hypoxic-ischaemic insult.
- Symptoms include neonatal-onset encephalopathy, intractable seizures, and feeding/respiratory issues.
Observation:
- A case of an 8-year-old boy with severe neurological manifestations since birth, but without significant seizures, is presented.
- This presentation highlights the variability in clinical presentation, particularly the absence of seizures.
- The patient's neuroimaging findings were consistent with hypoxic-ischaemic encephalopathy.
Findings:
- Molybdenum cofactor deficiency should be considered in newborns with unexplained encephalopathy and imaging suggestive of hypoxic-ischaemic insult.
- Key diagnostic laboratory findings include low serum uric acid, positive urine sulfite tests, and elevated urinary S-sulfocysteine, hypoxanthine, and xanthine.
- This case underscores the importance of considering rare metabolic disorders in neonatal encephalopathy.
Implications:
- Early identification and diagnosis of molybdenum cofactor deficiency are critical for timely intervention.
- Recognizing this disorder can prevent misdiagnosis as hypoxic-ischaemic insult, allowing for appropriate management.
- This case expands the understanding of the clinical spectrum of molybdenum cofactor deficiency.
Related Concept Videos
Inborn Errors of Metabolism
Cytomegalovirus Disease
Cofactors and Coenzymes
Rocky Mountain Spotted Fever
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life


